menu search

MiNK Therapeutics to Participate in September Investor Conferences

MiNK Therapeutics to Participate in September Investor Conferences
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that Dr. Jennifer Buell, Chief Executive Officer and President, will participate in the […] The post MiNK Therapeutics to Participate in September Investor Conferences... Read More
Posted: Aug 24 2023, 12:30
Author Name: forextv
Views: 111796

Search within

Pages Search Results: